Catalyst Wire Dossier Catalyst Wire Dossier

Myrbetriq

mirabegron · Astellas Pharma Inc.
Drug timelines are a Plus or Pro feature.

48 regulatory and trial events tracked for Myrbetriq, covering 2012-06-28 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: A Pilot Study of Mirabegron and Montelukast in Cirrhotic Patients [Phase 4]

See pricing